Updated Oct 27, 2026 · 08:54 UTC
REGNRegeneron Pharmaceuticals, Inc.
Health Care · United States · XNAS · pharmaceutical preparations
$808.99+0.33%last session · market early-hours
Market cap
$83.29b
real-world
Tokenized
$12k
<0.001% of the asset
Avg token price
$806.40
−0.32% vs real
Spot volume, 24h
—
Derivatives, 24h
—
Perp open interest
—
In DeFi
—
REGN · Price
Token Real
EarningsNasdaq’s earnings calendar
Next earnings
Oct 30
before the open · Sep 2026 quarter · EPS forecast $13.76 (6 analysts)
Last earnings, Jul 30
$12.53 EPS
+56.6% vs $8.00 forecast · Jun 2026 quarter
Real marketRegeneron Pharmaceuticals Inc
Last close
$805.02
Oct 23
Traded on Oct 23
$425.5m
Price now
$808.99
market early-hours
Where it trades24h volume by venue, as the exchanges report it · open interest and funding on the perpetuals
Spot · — · 0 venues
None yet
Derivatives · — · 0 venues
None yet
In DeFiPools and lending markets that hold these tokens
None found
Onchain versions2 tokens from 2 issuers
REGNonOndo Assetstied here$806.40$12k
wREGNxBacked Assets——HoldersAddresses holding its tokens on each chain counted, each token counted and added, issuers’ own addresses left out · the value is what they hold onchain
BNB Chain56 holders$10k
Ethereum16 holders$2k
Solana4 holders$9Business 12 months to Jun 2026 · SEC EDGAR
Results
Revenue
$15.53b
+9% YoY
Operating income
$3.84b
25% margin · +0% YoY
Net income
$4.33b
28% margin · −3% YoY
EPS, diluted
$40.84
−1% YoY
Diluted shares
106m
−2% YoY
Cash and balance sheet
Free cash flow
$3.76b
24% of revenue · 4.5% yield
Net cash
$15.84b
$17.82b cash and securities, $1.99b debt
Quarterly
RevenueNet income
Valuation today’s market cap $83.29b · enterprise value $67.45b
P/E
19.2×
EV / sales
4.3×
EV / op. income
17.6×